No Data
No Data
Fresenius Medical Care To Go Ex-Dividend On May 27th, 2025 With 0.7871 USD Dividend Per Share
Analysts Conflicted on These Healthcare Names: Spyre Therapeutics (SYRE), Fresenius Medical Care (FMS) and Jazz Pharmaceuticals (JAZZ)
Deutsche Bank Maintains Investment Decision on Fresenius Medical Post Upbeat Q1 Earnings
Goldman Sachs Sticks to Their Buy Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Berenberg Bank Keeps Their Buy Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care